InvestorsHub Logo

~MulaGreen~

05/18/21 8:37 AM

#3842 RE: ~MulaGreen~ #3837

Medolife has been researching Escozine® as a potential treatment for COVID-19 in clinical research programs in both the United States and the DR.
The Company has completed an Investigational New Drug (IND) filing on Escozine® through the US Food and Drug Administration (FDA) and is awaiting a response.
In the DR, and upon approval from the medical ethics committee, it will commence a double-blind placebo human study on Escozine®, which would mark a substantial step forward in Escozine's path toward worldwide registration and adoption.

https://newsfilter.io/a/3216e51dd6b440faffe147f9be46e438

This Answers All The Speculations.

Skiluc

05/18/21 8:44 AM

#3844 RE: ~MulaGreen~ #3837

This is the stuff massive corporations start from. Was that the spark? If not, one is certainly bound to come?

Whats like 5 sparks equal these days?

QNTA will find out. Promise.